NIH-funded research R21 grant

Investigating how vaping affects nicotine and its safety

Official title: Effects of vaping-induced oxidation on nicotine analogs e-cigarettes

Funded at Univ of North Carolina Chapel Hill · NIH-11119068 · Data updated 2026-11-12

This study looks at how vaping changes the makeup of nicotine products, especially a new type called 6-methyl nicotine, to see how it affects the health and addiction risks for teens and young adults, helping to find ways to keep people safer from vaping's dangers.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startApril 1, 2025
Project endMarch 31, 2027
Funding year2025
Award (this year)$265,239
NIH project number1R21DA062849-01
Project IDNIH-11119068 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adolescents and young adults who currently use or have used vaping products.

Less likely to help

Patients who do not use vaping products or are not interested in nicotine-related research may not benefit from this study.

What this research studies

This research explores the impact of vaping on the chemical composition of nicotine products, particularly focusing on a new form of nicotine called 6-methyl nicotine. It aims to understand how vaping alters the toxicity and addictive properties of these substances, especially among adolescents and young adults. By analyzing the aerosol produced from vaping devices, the study seeks to identify harmful compounds that may pose health risks. The findings could inform regulatory measures and public health strategies to mitigate the dangers associated with vaping.

Why it matters

Potential benefit: If successful, this research could lead to safer vaping products and better public health guidelines for young users.

How similar studies have gone: Previous research has indicated significant health risks associated with vaping, but this specific investigation into 6-methyl nicotine is relatively novel.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Corteselli, Elizabeth Marie — Univ of North Carolina Chapel Hill
  • Study coordinator: Corteselli, Elizabeth Marie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.